Current position:Home >Product >
2-[(8-hexyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetamide
2-[(8-hexyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetamide(372157-10-3)
- Name: 2-[(8-hexyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetamide
- Synonyms:2-[(8-hexyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetamide;Acetamide, 2-[(8-hexyl-1,2,3,4-tetrahydro-4-oxocyclopenta[c][1]benzopyran-7-yl)oxy]-
- Molecular Formula:C20H25NO4
- Molecular Weight:343.42
- CAS Registry Number:372157-10-3
- EINECS:
- Melting Point:586.2±50.0 °C(Predicted)
- Water Solubility:
Other Product
- 372098-20-9/3-(4-chlorophenyl)-1-phenyl-1H-pyrazole-4-carboxamide
- 372107-97-6/Biotin-PEG3-Mal
- 372109-26-7/N-[2-(1H-Indol-3-yl)ethyl]-1-butanesulfonamide
- 372112-40-8/2H-Naphth[2,3-d]imidazol-2-ylidene, 1,3-dihydro-, radical ion(1-) (9CI)
- 372115-54-3/5-Pyrimidinecarboxamide, N-[(3-chloro-4-methoxyphenyl)methyl]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-4-[(2-pyrimidinylmethyl)amino]-
- 372118-66-6/C-Pyrimidin-2-yl-methylamine, fummerate
- 372119-50-1/Carbamic acid, N-[(1S,2S)-2-hydroxy-3-methyl-1-(phenylmethyl)-3-buten-1-yl]-, 1,1-dimethylethyl ester
- 372137-02-5/SaflufecilImpurity3
- 372144-23-5/3-(9 H-Fluoren-9-ylmethoxycarbonylamino)-3-pyridin-4-yl-propionic acid
- 372144-25-7/3-Pyridinepropanoic acid, β-[[(phenylmethoxy)carbonyl]amino]-
- 372146-18-4/IKKγ NBD Inhibitory Peptide
- 372146-20-8/-Defensin-2 (human) (trifluoroacetate salt)
- 372152-75-5/2,4-Dibromo-6-(3-methyl-1,2,4-oxadiazol-5-yl)phenol
- 37215-41-1/37215-41-1
- 372154-69-3/2,6-dimethyl-1-(2-methyl-5-nitrophenyl)-5-phenylpyrimidin-4(1H)-one
- 372154-84-2/D-erythro-Hexonic acid, 2,4-dideoxy-, 1,1-dimethylethyl ester
- 372155-32-3/8-hexylsulfanyl-7-(2-methoxyethyl)-3-methylpurine-2,6-dione
- 372156-64-4/N-(3-fluorophenyl)-4-hydroxy-2-oxo-1-prop-2-enylquinoline-3-carboxamide
- 372156-82-6/SCH 350581 dihydrochloride
- 372157-10-3/2-[(8-hexyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetamide
- 372157-48-7/ethyl 2-[6-amino-5-cyano-4-(2-fluorophenyl)-2,4-dihydropyrano[2,3-c]pyrazol-3-yl]acetate
- 372163-83-2/7-Ethyl-1H-furo[2,3-g]indazole
- 372164-79-9/(3Z)-3-[(1H-imidazol-5-yl)methylidene]-2,3-dihydro-1H-indol-2-one
- 372172-28-6/3-[(4-fluorophenyl)methyl]-5H-pyrimido[5,4-b]indol-4-one
- 372172-56-0/1,2,5-Oxadiazol-3(2H)-one, 4-methoxy-
- 372173-30-3/8-(N-Benzylidene-hydrazino)-3-methyl-7-(2-methyl-allyl)-3,7-dihydro-purine-2,6-dione
- 372174-80-6/N-(3,5-dimethylphenyl)-1-ethyl-4-hydroxy-2-oxoquinoline-3-carboxamide
- 3721-76-4/Isoquinolinium, 1,2,3,4-tetrahydro-6-hydroxy-1-(p-hydroxybenzyl)-7-methoxy-2,2-dimethyl-, hydroxide (8CI)
- 372178-53-5/Cyclopropanecarboxylic acid, 3-(2-fluoro-5-methoxyphenyl)-2,2-dimethyl-, (1R,3R)-rel-
- 372179-20-9/4-(3-(o-tolyloxy)propyl)Morpholine